Login
Home
Charts
Search
Watchlist
Products

Chambal Fertilisers & Chemicals Ltd

CHAMBLFERT·NSE
420.05+0.37%Wed, 23 Sept '26 13:16

Chambal Fertilisers & Chemicals Ltd

CHAMBLFERT
NSE
420.05
+0.37%
|Wed, 23 Sept '26 13:16
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
16,827Cr
Close
Close Price
420.00
Industry
Industry
Fertilisers
PE
Price To Earnings
8.73
PS
Price To Sales
0.84
Revenue
Revenue
20,123Cr
Rev Gr TTM
Revenue Growth TTM
15.58%
PAT Gr TTM
PAT Growth TTM
10.17%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
5,3864,3492,6434,9334,3464,9182,4495,6986,4135,8982,7855,027
Growth YoY
Revenue Growth YoY%
-37.3-47.6-26.6-11.7-19.313.1-7.315.547.519.913.7-11.8
Expenses
ExpensesCr
4,7713,7202,4774,1813,5564,1402,2854,9375,5715,0782,5304,176
Operating Profit
Operating ProfitCr
615628167752790778163761842821255851
OPM
OPM%
11.414.46.315.218.215.86.713.413.113.99.216.9
Other Income
Other IncomeCr
901517386809586798836532
Interest Expense
Interest ExpenseCr
46363640170211317
Depreciation
DepreciationCr
787978828383828487889089
PBT
PBTCr
581664126716786783168754842768215747
Tax
TaxCr
200205292682492483720519318246223
PAT
PATCr
38145997448536534130549649586169524
Growth YoY
PAT Growth YoY%
38.941.83.032.440.816.334.622.420.99.729.9-4.6
NPM
NPM%
7.110.63.79.112.310.95.39.610.19.96.110.4
EPS
EPS
9.211.02.511.213.413.33.313.716.214.64.213.1
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
5,3864,3492,6434,9334,3464,9182,4495,6986,4135,8982,7855,027
Growth YoY
Revenue Growth YoY%
-37.3-47.6-26.6-11.7-19.313.1-7.315.547.519.913.7-11.8
Expenses
ExpensesCr
4,7713,7202,4774,1813,5564,1402,2854,9375,5715,0782,5304,176
Operating Profit
Operating ProfitCr
615628167752790778163761842821255851
OPM
OPM%
11.414.46.315.218.215.86.713.413.113.99.216.9
Other Income
Other IncomeCr
901517386809586798836532
Interest Expense
Interest ExpenseCr
46363640170211317
Depreciation
DepreciationCr
787978828383828487889089
PBT
PBTCr
581664126716786783168754842768215747
Tax
TaxCr
200205292682492483720519318246223
PAT
PATCr
38145997448536534130549649586169524
Growth YoY
PAT Growth YoY%
38.941.83.032.440.816.334.622.420.99.729.9-4.6
NPM
NPM%
7.110.63.79.112.310.95.39.610.19.96.110.4
EPS
EPS
9.211.02.511.213.413.33.313.716.214.64.213.1

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
9,0087,5537,54110,09512,20612,71916,06927,77317,96616,64620,79420,123
Growth
Revenue Growth%
-7.5-16.1-0.233.920.94.226.372.8-35.3-7.324.915.6
Expenses
ExpensesCr
8,2526,7776,7458,88210,30410,25613,80725,95315,92314,16318,11517,355
Operating Profit
Operating ProfitCr
7567767971,2121,9022,4632,2621,8192,0432,4832,6782,768
OPM
OPM%
8.410.310.612.015.619.414.16.511.414.912.913.8
Other Income
Other IncomeCr
49136181-2215475374225330347256178
Interest Expense
Interest ExpenseCr
26625415524650328910632017348721
Depreciation
DepreciationCr
1119285119287289300308313330349354
PBT
PBTCr
4285667378461,3282,3602,2311,4161,8872,4522,5782,572
Tax
TaxCr
160186245247101612665383611802625644
PAT
PATCr
2683804925991,2271,7481,5661,0341,2761,6491,9531,928
Growth
PAT Growth%
-4.342.029.421.7104.942.5-10.4-34.023.429.318.410.2
NPM
NPM%
3.05.06.55.910.113.79.83.77.19.99.49.6
EPS
EPS
5.38.712.014.229.539.837.624.930.841.248.848.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
9,0087,5537,54110,09512,20612,71916,06927,77317,96616,64620,79420,123
Growth
Revenue Growth%
-7.5-16.1-0.233.920.94.226.372.8-35.3-7.324.915.6
Expenses
ExpensesCr
8,2526,7776,7458,88210,30410,25613,80725,95315,92314,16318,11517,355
Operating Profit
Operating ProfitCr
7567767971,2121,9022,4632,2621,8192,0432,4832,6782,768
OPM
OPM%
8.410.310.612.015.619.414.16.511.414.912.913.8
Other Income
Other IncomeCr
49136181-2215475374225330347256178
Interest Expense
Interest ExpenseCr
26625415524650328910632017348721
Depreciation
DepreciationCr
1119285119287289300308313330349354
PBT
PBTCr
4285667378461,3282,3602,2311,4161,8872,4522,5782,572
Tax
TaxCr
160186245247101612665383611802625644
PAT
PATCr
2683804925991,2271,7481,5661,0341,2761,6491,9531,928
Growth
PAT Growth%
-4.342.029.421.7104.942.5-10.4-34.023.429.318.410.2
NPM
NPM%
3.05.06.55.910.113.79.83.77.19.99.49.6
EPS
EPS
5.38.712.014.229.539.837.624.930.841.248.848.1

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
416416416416416416416416401401401
Reserves
ReservesCr
1,4681,7252,1042,4783,1314,8375,9866,6526,8738,32710,007
Current Liabilities
Current LiabilitiesCr
5,0084,3913,3096,5256,6781,5253,8023,1522,0371,1742,555
Non Current Liabilities
Non Current LiabilitiesCr
1,3261,6253,7364,6164,4233,4853,1012,5652,2141,5211,457
Total Liabilities
Total LiabilitiesCr
8,1248,0579,46313,92614,53310,24713,28912,77011,50911,40714,402
Current Assets
Current AssetsCr
5,2564,8703,7736,5057,3253,1486,0755,6394,0893,6225,962
Non Current Assets
Non Current AssetsCr
2,8683,1875,6907,4217,2077,0997,2147,1317,4207,7858,440
Total Assets
Total AssetsCr
8,1248,0579,46313,92614,53310,24713,28912,77011,50911,40714,402
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
416416416416416416416416401401401
Reserves
ReservesCr
1,4681,7252,1042,4783,1314,8375,9866,6526,8738,32710,007
Current Liabilities
Current LiabilitiesCr
5,0084,3913,3096,5256,6781,5253,8023,1522,0371,1742,555
Non Current Liabilities
Non Current LiabilitiesCr
1,3261,6253,7364,6164,4233,4853,1012,5652,2141,5211,457
Total Liabilities
Total LiabilitiesCr
8,1248,0579,46313,92614,53310,24713,28912,77011,50911,40714,402
Current Assets
Current AssetsCr
5,2564,8703,7736,5057,3253,1486,0755,6394,0893,6225,962
Non Current Assets
Non Current AssetsCr
2,8683,1875,6907,4217,2077,0997,2147,1317,4207,7858,440
Total Assets
Total AssetsCr
8,1248,0579,46313,92614,53310,24713,28912,77011,50911,40714,402

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-271,2801,172-1,1308276,944-243,2393,3271,394138
Investing Cash Flow
Investing Cash FlowCr
-339-691-1,778-1,125-455-196-119-1,873-382739-482
Financing Cash Flow
Financing Cash FlowCr
362-5005642,263-283-6,007-213-1,862-2,871-2,135543
Net Cash Flow
Net Cash FlowCr
-489-43889740-356-49673-2199
Free Cash Flow
Free Cash FlowCr
-665400-1,250-2,3341776,709-1863,0462,720825-748
CFO To PAT
CFO To PAT%
-9.9336.6238.3-188.867.4397.3-1.6313.3260.884.57.0
CFO To EBITDA
CFO To EBITDA%
-3.5164.8147.1-93.243.5281.9-1.1178.0162.856.15.1
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
-271,2801,172-1,1308276,944-243,2393,3271,394138
Investing Cash Flow
Investing Cash FlowCr
-339-691-1,778-1,125-455-196-119-1,873-382739-482
Financing Cash Flow
Financing Cash FlowCr
362-5005642,263-283-6,007-213-1,862-2,871-2,135543
Net Cash Flow
Net Cash FlowCr
-489-43889740-356-49673-2199
Free Cash Flow
Free Cash FlowCr
-665400-1,250-2,3341776,709-1863,0462,720825-748
CFO To PAT
CFO To PAT%
-9.9336.6238.3-188.867.4397.3-1.6313.3260.884.57.0
CFO To EBITDA
CFO To EBITDA%
-3.5164.8147.1-93.243.5281.9-1.1178.0162.856.15.1

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,2833,6026,7686,9304,4999,52317,56410,99013,70625,06517,08216,827
Price To Earnings
Price To Earnings
10.39.913.611.73.75.811.210.610.715.28.78.7
Price To Sales
Price To Sales
0.30.50.90.70.40.81.10.40.81.50.80.8
Price To Book
Price To Book
1.21.72.72.41.31.82.71.61.92.91.61.6
EV To EBITDA
EV To EBITDA
9.610.416.012.87.25.19.47.87.610.06.66.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
19.022.022.321.125.027.920.110.717.721.419.319.3
OPM
OPM%
8.410.310.612.015.619.414.16.511.414.912.913.8
NPM
NPM%
3.05.06.55.910.113.79.83.77.19.99.49.6
ROCE
ROCE%
10.112.110.49.414.128.821.816.622.528.322.522.5
ROE
ROE%
14.217.819.520.734.633.324.514.617.518.918.818.8
ROA
ROA%
3.34.75.24.38.417.111.88.111.114.513.613.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2,2833,6026,7686,9304,4999,52317,56410,99013,70625,06517,08216,827
Price To Earnings
Price To Earnings
10.39.913.611.73.75.811.210.610.715.28.78.7
Price To Sales
Price To Sales
0.30.50.90.70.40.81.10.40.81.50.80.8
Price To Book
Price To Book
1.21.72.72.41.31.82.71.61.92.91.61.6
EV To EBITDA
EV To EBITDA
9.610.416.012.87.25.19.47.87.610.06.66.2
Profitability Ratios
Profitability Ratios
GPM
GPM%
19.022.022.321.125.027.920.110.717.721.419.319.3
OPM
OPM%
8.410.310.612.015.619.414.16.511.414.912.913.8
NPM
NPM%
3.05.06.55.910.113.79.83.77.19.99.49.6
ROCE
ROCE%
10.112.110.49.414.128.821.816.622.528.322.522.5
ROE
ROE%
14.217.819.520.734.633.324.514.617.518.918.818.8
ROA
ROA%
3.34.75.24.38.417.111.88.111.114.513.613.6
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Chambal Fertilisers & Chemicals is India’s largest private-sector urea maker - a business built on feeding the country’s crops - but it has quietly evolved into a single-window shop for everything a farmer needs, from seeds to specialty nutrients. It started in 1985 at a single site in Gadepan, Rajasthan, and over four decades layered on new engines - complex fertilisers, crop protection chemicals, biologicals, and now industrial chemicals - each funded by the steady cash flows of the one before. The recurring approach is simple: use the deep distribution network and farmer trust earned in urea to pull through higher-margin products, all under one “Uttam” brand roof. # Business segments Five engines at different stages - a regulated urea cash cow, an asset-light fertiliser trading business, a fast-growing consumer agri-inputs platform, a greenfield industrial chemicals bet under construction, and a Moroccan joint venture that supplies the raw material - each built with the cash flows of the one before. ## 1. Urea: the regulated foundation that pays for everything else **The company makes and sells more urea than any other private player in India, at government-set prices, from one of the world’s most energy-efficient single-location complexes - so the margin comes from operational excellence, not pricing power.** - **Price fixed by the government** - urea’s Maximum Retail Price for farmers is set by statute, and the company receives a subsidy from the Government of India, which considers the gas price while fixing the subsidy for urea units up to the Re-Assessed Capacity. - **Scale that rivals cannot easily replicate** - three plants at Gadepan together produce 3.4 million metric tonnes a year, roughly 10% of India’s domestic urea, making it the largest single-location urea facility in the country. - **Energy efficiency is the real moat** - the complex ranks among the most energy-efficient globally, and the company invested Rs. 227.84 crore by the end of March 2024 in energy-saving schemes that cut greenhouse gas emissions by 91,875 metric tons of CO₂, directly lowering the cost of every tonne produced. - **Geography insulates it from new competition** - the company concentrates its supplies of Urea in northern and central India, while new urea plants are located in the eastern and southern parts of India, so its existing dealer relationships face less direct threat. - **Surplus ammonia is a bonus** - the plants produce more ammonia than urea-making needs, and this excess is sold in the open market, but sales volumes were lower in FY25 than the previous year. ## 2. Complex fertilisers: an asset-light trading business on the same shelf **The company does not make these fertilisers - it buys DAP, MOP, and NPK blends from international suppliers and sells them through the same dealer network that moves its urea, earning a margin on the spread without owning factories.** - **Imported, not manufactured** - India imports all its MOP and over half its DAP, and CFCL sources these from a diversified base across Southeast Asia, Africa, Canada, Russia, and China, reducing the risk of any single supplier disruption. - **Deep state-level share in its territory** - in Bihar, the company holds a 31% share of the MOP market and 10% of DAP; in Chhattisgarh, 12% of MOP and 7% of DAP, showing concentrated strength where it chooses to compete. - **Seasonal portfolio management** - volumes of MOP, NPK, and DAP are contracted based on seasonal demand patterns, so the company avoids getting caught with expensive inventory when the planting season ends. ## 3. Crop protection, specialty nutrients, biologicals and seeds: the future margin engine **This is the non-subsidised, higher-margin business where CFCL sells insecticides, fungicides, water-soluble fertilisers, proprietary biological products, and seeds under the “Uttam” brand - mostly procured from global innovators and formulators, then pushed through an expanding retail channel that goes beyond fertiliser dealers.** - **Bought, not just built** - the company sources 62 distinct chemical formulations from leading American, European, Japanese, and domestic manufacturers and sells them under its own brand, positioning itself as a price-competitive alternative to multinational labels. - **Proprietary biologicals are the differentiator** - UTTAM PRANAAM, a biogenic nano-phosphorus product, and UTTAM SUPERRHIZA, an award-winning mycorrhiza biofertilizer, are developed in-house and have already covered nearly 3 million acres since launch, giving the company products that competitors cannot simply copy. - **Seeds complete the basket** - entry into wheat, maize, mustard, and bajra seeds during FY25 means the company now offers every major agri-input a farmer buys in a season, locking in the “one roof” promise. - **A dedicated channel is being built** - while the fertiliser dealer network provides a base, the CPC business is expanding into its own retail footprint across 262 districts with roughly 4,000 dealers, using loyalty programmes and a “Seed-to-Harvest” advisory model to pull farmers in. - **Research pipeline with TERI** - a five-year partnership with The Energy and Resources Institute funds end-to-end R&D to develop 10 novel patented products in Crop Protection and Crop Nutrition category, so the product shelf keeps refreshing with science-backed launches. ## 4. Technical Ammonium Nitrate: the industrial bet under construction **A greenfield plant at the same Gadepan site will turn surplus ammonia into explosive-grade ammonium nitrate for mining and infrastructure - a completely new customer base, built with the company’s existing chemical-plant expertise and captive feedstock.** - **Captive ammonia is the strategic advantage** - the company already produces more ammonia than its urea plants consume and sells the surplus; the TAN plant will consume that ammonia internally, upgrading a commodity into a higher-value industrial product. - **Three product forms for different buyers** - the plant will produce solid prilled ammonium nitrate (HDAN) for packaged explosives, a liquid melt (ANSOL) for bulk emulsion explosives delivered in dedicated tankers, and Weak Nitric Acid as an intermediate for chemical and metallurgical industries. - **Demand is growing faster than supply** - India’s TAN market of about 1.2 million tonnes is in deficit, with explosive-segment demand growing at 6-7% annually and roughly 70,000 tonnes of incremental demand each year, so a new domestic supplier enters a seller’s market. - **World-class technology, delayed execution** - the plant uses process technology from Casale of Switzerland with Larsen & Toubro as the turnkey contractor, but completion has been pushed to April 2026 due to contractor-side delays; Weak Nitric Acid production began in June 2026 as the first step toward full commissioning. # Group structure and partners **The company’s most valuable external relationship is a one-third stake in a Moroccan phosphoric acid joint venture that is expanding to become one of the world’s largest and lowest-cost producers - securing a critical raw material for India’s fertiliser industry.** - **IMACID: equal partners, strategic supply** - CFCL, Tata Chemicals, and Morocco’s OCP each own 33.33% of Indo Maroc Phosphore S.A., which produces phosphoric acid and delivers stable equity earnings to CFCL. - **Capacity expansion underway** - IMACID’s phosphoric acid capacity is being raised from 5 lakh to 7 lakh metric tonnes, with completion expected by December 2026, at what management calls the lowest capital cost per tonne globally for a project of this scale. - **Dormant subsidiaries only** - CFCL has three subsidiaries (one in the Cayman Islands with US and Indian step-down entities, and one Indian infrastructure vehicle), none of which conducted any business activity during FY25; two older entities were dissolved in 2021.

Documents — Chambal Fertilisers & Chemicals Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/imfnymo961o1mltyj0rb2wux.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/os5hdjb2kdckqj1asat11gc4.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/11k99h1r8vpfs9b4rt3j6arh.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/p1lwtfhqm0oo5m21fhpf0xbn.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/j5a9nfr5w4o24fkfbii3daif.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/un3r98x5d0hap9duhglr2gke.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/czo4lbqs1exiuki2u9hyaw7c.pdf
  • Q1 FY2025 Earnings Call Transcript (Jun 2024, PDF): https://www.stockscans.in/document/f3gwo5a2gkbqi3pwfnposcdd.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/a4bjjvk8ewy7niqhbvjj60qk.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/y0fes6wnzsopto8aq5h0e27p.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/qgzatomf566zlzok12wpujww.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/p588puxj0mdf8qf1i833swt3.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/dtkxrtets1lq2i6wzds9m0m7.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/b4p6028oo9cwvll1cvuqvead.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/8k34agempbags11k7e58zgnn.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/q3kpu1rdbpnzd05nr2zxhhkz.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/65utyctyyilj6a8xk3o9f0ox.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/8r44ai4rzpdw21ze32fz7l57.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/r6qwhr08mv08etawrkc8mhtq.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/zoquqoy3co3vbpjcxxtzauwd.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/0pw2y38nj5vpnmavmemot6k9.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/hczga1iou17g1nojk4zwf9mc.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/7tpx9xxbdhxwnruagjg41uqu.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/nnt2p3uv8sg8k15jvnhkcli0.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/4x94yfwh8onvc4u4pug73uvm.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/aguwr4fel7t9ti3tfh7i1cc8.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/43d54o079wlf2vznqhq0rcaa.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/o5swn1biaz331g340cprjuz7.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/zwtt8bc0ghxfsl67gw2jkqkv.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/a5jkbk0clt39r4tn7kpikzlv.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/6ygl7p803sa1br51fnglh3fy.pdf

Concall Transcript Summaries — Chambal Fertilisers & Chemicals Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3ACHAMBLFERT/transcript-notes/202606/imfnymo961o1mltyj0rb2wux.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ACHAMBLFERT/transcript-notes/202603/os5hdjb2kdckqj1asat11gc4.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3ACHAMBLFERT/transcript-notes/202512/11k99h1r8vpfs9b4rt3j6arh.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ACHAMBLFERT/transcript-notes/202509/p1lwtfhqm0oo5m21fhpf0xbn.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3ACHAMBLFERT/transcript-notes/202503/j5a9nfr5w4o24fkfbii3daif.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3ACHAMBLFERT/transcript-notes/202412/un3r98x5d0hap9duhglr2gke.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3ACHAMBLFERT/transcript-notes/202409/czo4lbqs1exiuki2u9hyaw7c.pdf
  • Q1 FY2025 Concall Transcript Summary (Jun 2024): https://www.stockscans.in/company/NSE%3ACHAMBLFERT/transcript-notes/202406/f3gwo5a2gkbqi3pwfnposcdd.pdf